Press Releases


Eppendorf supports the smartLAB project – the intelligent lab of the future – The special exhibit premiers at LABVOLUTION

Hamburg, October 2015

Eppendorf AG will be presenting the incorporation of its laboratory devices and consumables into digitalized work processes at the smartLab stand. The advantages this brings to the customer with regard to topics such as documentation, process monitoring and automation of repeatedly performed tasks in the laboratory are illustrated by means of practical examples. Dr. Jan-Gerd Frerichs, director of Information Integration at Eppendorf AG, explains: "As a premium supplier in the Life Science field, customer requirements are a top priority at Eppendorf. LABVOLUTION and smartLAB are the ideal forum for us to present tomorrow's trends in an interdisciplinary environment. Moreover, it is a perfect opportunity to interact directly with our customers and to find out what they think about it."

Intelligent, networked and automated - those are the key properties of the lab of the future. From October 6 to October 8 in Hanover, smartLAB will present a glimpse into the future and invite you to find out what is already possible now. "smartLAB - the intelligent lab of the future" is a special exhibit that will now be held at the new LABVOLUTION fair for the first time. For the past year, twelve partners from science and industry have teamed up to create a realistic vision of a laboratory of the future. Application scenarios performed live show how digitization will change life in the lab and how we can benefit from that development. The fair also includes the forum event Laboratory 4.0 in an area of 400 square meters.


Eppendorf AG: Hall 9, Booth F13

SmartLab: Hall 9, Booth E67


Eppendorf – your expert and advisor all around the laboratory at the BIOTECHNICA 2015

Hamburg, October 2015

The Eppendorf AG will be present itself at the BIOTECHNICA in two adjacent booths on a total exhibition area of 260m², focusing on the topic “Take Good Care of Your Cells”. This year’s novel products include the Centrifuge 5920R, the ultra-deep freezer CryoCube F570, the Multipette E3/E3x (an electronic hand dispenser) as well as the BioFlo 320 from the area of Bioprocessing.

Three times daily (11:00 am, 2:00 pm and 4:00 pm) visitors will be invited to join guided tours of the transparent laboratory, covering the main topic “Cell Biology”. For almost 70 years, innovative technologies and premium products by Eppendorf have contributed to improving work processes in laboratories and research facilities around the world. The product portfolio includes highly reliable, long-lasting instruments, matching consumables and tailored accessories to make the daily laboratory routine easier and at the same time more efficient and reproducible.

"We have gained a deep understanding of different laboratory workflows through our close and long-established relationship with the scientific community," says Dr. Tanja Musiol, Global Project Leader Workflows, Cell Handling Procedures and PhysioCare at Eppendorf AG. "To share this knowledge and deepen it further at the same time, we engage in a personal and application-oriented dialog with our customers on-site at the BIOTECHNICA 2015 and talk about their requirements regarding processes and the daily routine at the laboratory."

For this purpose, Eppendorf built a glass laboratory at the exhibition and offers guided laboratory tours. During these tours, the application experts explain typical applications and processes in the cell-biological / bioprocess laboratory. Day-to-day tasks are discussed with the customer directly on-site. During personal conversations, application-oriented approaches to gain reliable results are discussed with the experts.



This can mean an optimization of the entire laboratory process or small changes of the daily routine at the laboratory. Our experts give tips to avoid contaminations in the cell culture as well as advice on how to reach a homogeneous and reproducible cell growth. They also present intelligent solutions that reduce the complexity in the daily laboratory work are also presented.

This year, in addition to the BIOTECHNICA, a new trade fair - the LABVOLUTION - will simultaneously take place in the same exhibition hall. This event features a space which will be dedicated to the subject area smartLAB – the laboratory of the future.  Eppendorf will also participate in this event with presentations and instruments, as well as with a small information area.

(SmartLab: Hall 9, Booth E67).

Visit us at BIOTECHNICA 2015, Hall 9, Booth F13


Thomas Bachmann is new Chief Executive Officer of the Eppendorf Group

Thomas Bachmann

Hamburg, August 3, 2015 – Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on an interim basis in addition to his responsibilities as CFO.

Bachmann, who has been a member of the Eppendorf Supervisory Board since 2013, came to Eppendorf from his position as President of the Bruker BioSpin Group. He has been active in the life science sector since 2005, when he took on the overall management of the globally active Tecan Group, which is headquartered in Switzerland.

"We are very pleased that we have been able to win Thomas Bachmann as our Chief Executive Officer," said Klaus Fink, Chairman of the Supervisory Board of the Eppendorf Group. "He has demonstrated his expertise and his strategic foresight in many ways during more than 25 years of experience in international management positions."

Bachmann explains: "Eppendorf is an innovative, customer-oriented company with a strong, well-known brand and a global orientation, and it succeeds again and again in making important contributions to analytic, medical, diagnostic and life science laboratories. I am looking forward to working with Eppendorf's very competent and committed global management to develop the company sustainably and successfully in the years to come."


Presentation of the 2015 Eppendorf Award for Young European Investigator to Thomas Wollert, This year’s research prize awarded by Eppendorf goes to Germany

Wilhelm Plüster (Eppendorf AG), Maria Leptin (EMBO), Award Winner 2015: Thomas Wollert (Max Planck Institute of Biochemistry), Reinhard Jahn (MPI for Biophysical Chemistry), Axel Ziemke (Eppendorf Vertrieb Deutschland GmbH), Axel Jahns (Eppendorf AG) - from left to right; ©EMBL Photolab

Hamburg, June 2015 -  In 2015 Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 20th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Dr. Thomas Wollert (Research Group Leader at the Max Planck Institute of Biochemistry in Martinsried, Germany) as the 2015 winner of the Eppendorf Award for Young European Investigators.

Thomas Wollert, born 1979, receives the € 20,000 prize for his groundbreaking work in reconstituting complex intracellular membrane events in the test tube using artificial membranes and purified components. His experiments have paved the way for understanding key steps in autophagy, a fundamental process required for the clearance of damaged cell parts in all eukaryotic cells. According to the Jury, these discoveries also harbor the potential for refined drug development since malfunction of autophagy is emerging as a critical event in the development of various diseases.

The Award ceremony took place at the EMBL Advanced Training Centre in Heidelberg, Germany, on June 25, 2015. The laudatio honoring Thomas Wollert’s achievements was held by the jury chairman Prof. Reinhard Jahn.

In his presentation, Thomas Wollert explained what autophagy is and which approaches he and his group Molecular Membrane and Organelle Biology are using to reveal how cells recycle damaged or superfluous components.

Thomas Wollert: “The major mission of my laboratory is to reveal the molecular mechanism of autophagy. We produce components of the autophagic recycling machinery and assemble them at model membranes to reveal their function. Our goal is to recapitulate autophagy in the test tube to understand how autophagy operates and what goes wrong in neurodegenerative diseases and cancer.” … “This prestigious Award honors the hard work of my laboratory and represents a major acknowledgement of our efforts aiming to decipher how cells maintain their homeostasis by autophagy. I am particularly grateful that our unusual bottom-up approach, which is based on biophysics in combination with biochemistry and cell biology, is being recognized by this Award.”

With the Eppendorf Young Investigator Award, which was established in 1995, Eppendorf AG honors outstanding work in biomedical research and supports young scientists in Europe up to the age of 35. The Eppendorf Award is presented in partnership with the scientific journal Nature. The Award winner is selected by an independent committee composed of Prof. Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany), Prof. Dieter Häussinger (Clinic for Gastroenterology, Hepatology and Infectiology, Düsseldorf, Germany), Prof. Maria Leptin (EMBO, Heidelberg, Germany), and Prof. Martin J. Lohse (Institute for Pharmacology and Toxicology, University of Würzburg, Germany).

More information about entry details, judging procedures, and past winners can be found at


More Capacity

Hamburg, June 2015 - Centrifuge 5920 R delivers extraordinary high capacity in a very compact and ergonomic product design. It has similar dimensions as competing refrigerated 3 Litre models and yet features a superior capacity of up to 4 x 1,000 mL; thus making it the ideal instrument for high-throughput applications. It features a powerful state-of-the-art refrigeration system with advanced temperature management to keep your samples safe.


DASGIP® Control is now DASware® control 5 – Parallel Processing Advances Bioprocess Development

Juelich, June 15, 2015 – With DASware control 5 Eppendorf presents its revised software for benchtop bioprocess control. The updated graphical user interface provides intuitive process views, user-defined functions, and configurable charts. Thanks to a new databaseand core architecture users benefit from faster loading times even with big datasets. Proven functionalities of current DASGIP Control have been improved, such as parallel calibration procedures, comprehensive recipe management, and the seamless integration of offline analytical data. Flexible setpoint profiles enable process automation.

The parallel design of the software facilitates implementation of Quality by Design approaches and accelerates process development. With DASware control 5, researchers and process engineers in both cell culture and microbiology can operate up to 16 benchtop bioreactors in parallel, with each vessel and process parameter individually monitored and controlled. Using the Eppendorf DASbox® Mini Bioreactor System, a single process computer can manage up to 24 bioreactors.

“Our new control software expands upon our established Point-Click-Grow concept for easy handling and integrated workflows.” explains Dr. Stephan Zelle, Product Manager Bioprocess at Eppendorf. “With editable templates it takes users only a few clicks to start their process. Automated reporting and smart tools further enhance data management and analysis of experimental runs.”

DASware control 5 is part of the parallel Eppendorf DASGIP and DASbox bioreactor systems. With DASware migrate, also users of New Brunswick™ and third-party bioreactor systems can benefit from the advantages of the Eppendorf DASware software suite.


Eppendorf at the ACHEMA 2015

Be part of the process

Hamburg, June 2015 - Eppendorf will particularly present its workflows on a booth of 238m² in total. Furthermore, several new products such as Centrifuge 5920R, CryoCube F570h as well as BioFlo 320 will be showcased. Experience the Eppendorf lab workflow in a guided tour at our ACHEMA booth, hall 4.1, booth D36. See our product highlights, lean how innovative product solutions could help to overcome common problems in the bioprocess/cell culture lab.

Guided Tour: 11:00 a.m. and 16:00 p.m.

Visit us at the ACHEMA 2015, Hall 4.1, Booth D36


Eppendorf licenses technology for thermal cyclers to Life Technologies

Hamburg, June 09, 2015 – Eppendorf AG has licensed European patent EP1426110B1 covering gradient technology for thermal cyclers to Life Technologies Corporation. Eppendorf utilizes the technology in its Eppendorf Mastercycler® pro gradient and Mastercycler nexus gradient models.


Eppendorf licenses technology for thermal cyclers to Alpha Laboratories Ltd

Hamburg, June 09, 2015 – Eppendorf AG has licensed European patent EP1426110B1 covering gradient technology for thermal cyclers to Alpha Laboratories. Eppendorf utilizes the technology in its Eppendorf Mastercycler® pro gradient and Mastercycler nexus gradient models.


Eppendorf back on sound course for growth

- Sales increase 5.7%
- Income from operations (EBIT) of approximately €95.7 million 

Hamburg, May 26, 2015 – In fiscal year 2014, the Eppendorf Group achieved sales of €531.1 million (prior year: €502.7 million), corresponding to a 5.7% increase when adjusted for currency effects. Income from operations (EBIT) rose to €95.7 million (prior year: €93.8 million), and 2014 net income declined to €65.7 million (prior year: €67.5 million).

In addition, significant capital investments were made in the further expansion of the company's sales structures and the set-up of production facilities, i.e. for the introduction of new product lines. Expenses for research and development also increased to €29.4 million (prior year: €28.2 million). The number of employees rose to 2,927 worldwide (prior year: 2,848).

Detmar Ammermann, Spokesman of the Management Board and Eppendorf's Chief Financial Officer: “The outstanding performance of our employees, our rigorous implementation of our strategies and the positive developments on the market all resulted in very positive sales growth of 5.7%. On the basis of this solid result, we will continue to pursue our strategic goals and increase customer benefit sustainably.”

this website uses cookies. By using our website, you agree to the use of cookies.

More informationGot it!